Peptide Research News - Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for ... - DigitalJournal.com (press release)

Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for ... - DigitalJournal.com (press release)

Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for ... DigitalJournal.com (press release) Intravail® comprises a broad class of transmucosal absorption enhancement agents that allow non-invasive systemic delivery of potent peptide, protein, nucleotide-related, and other small and large molecule drugs. The agreement will enable the ... and more »

Click Here to read the entire article...